Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-19

Clinical Trial Update: Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Nebivolol’s effect on oxidative stress and endothelial progenitor cells in hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

Sponsor: Emory University | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2014-12-19